Aveo appoints CFO
This article was originally published in Scrip
Executive Summary
Cambridge, Massachusetts-based Aveo Oncology has appointed Keith S Ehrlich chief financial officer. Mr Ehrlich will be responsible for the company's financial and administrative strategy and management, and will serve on the executive leadership team. He will report to Michael Bailey, Aveo's president and CEO. Mr Ehrlich was most recently CFO of Synta Pharmaceuticals. Prior to Synta, he held various senior finance and audit roles, including CFO of Argentys, Dyax and OraVax, director of finance of Vertex Pharmaceuticals and senior audit manager with PricewaterhouseCooper.
You may also be interested in...
Finding Value Left On The Shelf: Karuna Case Study
PureTech’s gamble to take an older Eli Lilly drug off the shelf to redevelop in a new indication paid off. The company aims to replicate this 'Karuna model' in the near future.
Podcast: NodThera On The Role Of The Brain In Driving Chronic Disease
Alan Watt, CEO of NodThera, a clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to treat chronic inflammatory diseases, talks to In Vivo about the company’s pipeline and recent data publication in the field of obesity.
Deals Of The Year 2023 Winners Revealed
For In Vivo's 16th annual Deals of the Year contest, we selected 12 nominees in three categories – Top Alliance, Top Financing and Top M&A. The polls are closed, and it is time to reveal the winners.